Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that its commercial partner Everest Medicines (HKEX …
![](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2023/10/pexels-photo-11348089.webp?resize=760%2C427&ssl=1)
![](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2023/10/pexels-photo-11348089.webp?resize=760%2C427&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that its commercial partner Everest Medicines (HKEX …
Shanghai Henlius Biotech, Inc. (2696.HK) has entered into an exclusive license agreement with Intas Pharmaceuticals …